Interestingly, a previous study in breast cancer suggests that increased SRC kinases activates the PI3K signaling cascade via altering the capacity of the PTEN C2 domain binding to the cellular membranes rather than directly interfering with PTEN enzymatic activity [39]. The gene discussed is PIK3CG; the disease is breast carcinoma.